HFA Premium Access

Discussion - Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients.

Congress Presentation

11 more presentations in this session

Reduction of Mitral Regurgitation in Patients with Heart Failure and Secondary Mitral Regurgitation: Relationship Between Baseline Biomarkers and Outcomes from the COAPT Trial

Speaker: Professor W. Abraham (Columbus, US)

Thumbnail

Discussion - COAPT.

Thumbnail

A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system

Speaker: Professor W. Abraham (Columbus, US)

Thumbnail

Discussion - A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system.

Thumbnail

Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients

Speaker: Professor D. Burkhoff (New York, US)

Thumbnail

Access the full session

Late breaking trial III - Innovative and device therapy

Speakers: Professor W. Abraham, Professor W. Abraham, Professor D. Burkhoff
Thumbnail

About the event

Image

Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk